Press Releases

WASHINGTON

The field has lost a giant in health care. Bernard Tyson was a champion for creating a more integrated and coordinated delivery system, and expanding coverage and access.

Today’s final rule from CMS regrettably ignores recent legal decisions while also putting even more pressure on hospitals and health systems that care for vulnerable patients and communities.

The AHA welcomes the nomination of Dr. Stephen Hahn, a renowned oncologist and physician leader, to be the next commissioner of the Food and Drug Administration. As the chief medical executive at The University of Texas MD Anderson Cancer Center, Dr. Hahn leads the medical practice at one of the world’s top hospitals devoted to cancer care, research, education and prevention. We believe that Dr. Hahn’s more than 20 years of experience on the front lines of delivering patient care, overseeing clinical research and operations, and quality and safety initiatives makes him a uniquely qualified nominee to lead the FDA.

AHA and AVIA Announce Strategic Alliance

Tom Nickels Executive Vice President American Hospital Association October 21, 2019

Now that Judge Collyer has ruled against both the government’s motion to reconsider her opinion and the motion for a stay, the AHA expects CMS to comply with today’s order and promptly repay the impacted hospitals to support the work they do for the patients they serve.

AHA applauds the Department of Health and Human Services for putting patients first and taking action to modernize the rules so they support, rather than hinder, the teamwork among health care providers that is so essential to providing the best, most comprehensive patient care.

Tom Nickels Executive Vice President American Hospital Association September 19, 2019